Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
about
Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombinVascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical ImplicationsHuman miR-221/222 in Physiological and Atherosclerotic Vascular RemodelingGene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulationANG II stimulates phospholipase D through PKCzeta activation in VSMC: implications in adhesion, spreading, and hypertrophyAngiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generationLabel-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretomeInvolvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cellsAngiotensin induces the urinary peristaltic machinery during the perinatal periodAngiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3.A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements.Renin-angiotensin system genes in kidney development.Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivationExpression of cell cycle regulators during smooth muscle cell proliferation after balloon catheter injury of rat arteryAutocrine and paracrine mechanisms in the early stages of diabetic nephropathy.A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.Impaired vascular contractility and aortic wall degeneration in fibulin-4 deficient mice: effect of angiotensin II type 1 (AT1) receptor blockade.The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells.Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes.Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury.Cell proliferation and protein synthesis as initial factors in determination of axial polarity.Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system.Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?Genetic engineering of vein grafts resistant to atherosclerosisIncrease in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injuryTransforming growth factor-beta1 (TGF-beta1): a potential recovery signal in the post-ischemic kidney.Renin-angiotensin system antagonism and lipid-lowering therapy in cardiovascular risk management.Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol dietTransforming growth factor beta in cardiovascular development and function.Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylationIncreased plasma chymase concentration and mast cell chymase expression in venous neointimal lesions of patients with CKD and ESRDANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression
P2860
Q22001441-278488AC-E01B-462B-B6A1-423D6919DAD2Q26749488-06673F62-CD1A-4AA7-8B33-FDA36EC38B11Q26801898-6956C23E-3FBA-473E-8581-5DBFB5FAA424Q28505894-F8B7F7AF-2FAE-4218-B80E-C620F585F3F3Q28571340-DE6F50E4-30A6-45CE-8A17-EB5EFB6B8E62Q28571898-0364ECA1-70CC-4E61-9DF8-3F45CB092EB1Q28573249-91F0EB08-D13E-4F52-933F-F90E95F4C99BQ28574951-126A6FCD-61EC-42A7-8BA7-C1191847AD2EQ28592988-99EE0F57-2F71-4857-8285-474FD0C90D07Q30433144-8EB267C4-87D9-4210-8635-20F4C9B54278Q30470269-E79C69C8-A1A1-4B72-AADE-8C2EEB8D6C3DQ30471290-4EAD62B2-FE27-4FAD-8A34-9E618E37C6C4Q30499402-72EFAAF8-647C-4FD9-8CAA-15A1C8AFD181Q33574889-92A78EEC-1A2A-4A80-9833-AD0CE617396BQ33631516-B53806DA-0BD0-42BA-AD6A-3190C343A687Q33793187-BA29C1B7-E278-4E7D-903C-1A9DF98059FCQ33853645-5CFCA4FA-26E6-482F-A38C-153420662DC8Q33900223-59DDFC91-8602-443F-A6E5-EA388B4CC1D2Q33902166-0E18DDE4-90F4-4159-A12D-E8FA8254D470Q33999588-B8BF29A6-36DB-4C2B-A2E8-4825DB49B23DQ34026411-EB2750A3-91CC-4B86-80AB-B5D20A358E26Q34120669-BADB6C8E-B6D4-4D02-8710-418C33914B17Q34127133-4257C29A-5976-401F-B411-FE5CCEDFB9C2Q34133039-19FF170B-ACDA-45EA-B8B9-F0FE79B3DEB9Q34150690-5011FD26-4E4F-4703-B068-BC3E1C527BBDQ34182616-5F004267-0020-4D8A-A66A-A1C3B08E0D6CQ34189204-5E4BE28F-5E2D-4201-B7F7-4B07FE1CC106Q34196093-8AAC833F-423F-460F-BE1A-55E09E7FD4EBQ34291442-73344FD1-38C7-46F9-AB60-F332A3322CFCQ34291477-07492F41-5758-4887-9E5F-906E0D9AF0A1Q34306932-2BA0FB3B-EC0D-4650-918C-5326E3A008CCQ34339752-A5902CA6-10C4-4B13-871F-042419AB905AQ34459819-AB834832-76FD-4D3E-9727-AF203F3B4F29Q34814841-AB685C0C-660D-41D1-B1FF-7D1A8CCCAFDCQ34849588-CEE48EDB-5D89-4878-BCAD-9A8C767DB83DQ35041595-A8D4E3C5-65CA-45F9-AB81-C155FFA84438Q35209142-50FDCB6A-2247-4FA2-9583-CD46F36A4932Q35314659-335D3445-8F00-4AA4-9171-7DCEEB6214CDQ35539717-12996444-B274-4D59-B33F-8F8BB7531153Q35552931-B2B67006-F7C6-4982-A181-3CDF87B917C7
P2860
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Vascular smooth muscle cell hy ...... th response to angiotensin II.
@ast
Vascular smooth muscle cell hy ...... th response to angiotensin II.
@en
type
label
Vascular smooth muscle cell hy ...... th response to angiotensin II.
@ast
Vascular smooth muscle cell hy ...... th response to angiotensin II.
@en
prefLabel
Vascular smooth muscle cell hy ...... th response to angiotensin II.
@ast
Vascular smooth muscle cell hy ...... th response to angiotensin II.
@en
P2093
P2860
P356
P1476
Vascular smooth muscle cell hy ...... th response to angiotensin II.
@en
P2093
P2860
P304
P356
10.1172/JCI115881
P407
P577
1992-08-01T00:00:00Z